Michael Churchman

8PUBLICATIONS
92CO-AUTHORS
Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 11, 2025
Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Robert L Hollis, Austin Miller, Heather A Lankes

|Jul 24, 2025
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.

Lena Rai, Antonella Ravaggi, Eliana Bignotti

|Jul 11, 2022
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.

Kelly L Bolton, Denise Chen, Rosario Corona de la Fuente

|Jun 13, 2022
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.

Robert L Hollis, Alison M Meynert, Caroline O Michie

|Nov 27, 2021
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma.

Robert L Hollis, Lorna J Stillie, Samantha Hopkins

|Oct 26, 2021
DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.

Julie M Cunningham, Stacey J Winham, Chen Wang

Pageof 2